Matches in SemOpenAlex for { <https://semopenalex.org/work/W1505831706> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W1505831706 endingPage "5" @default.
- W1505831706 startingPage "91" @default.
- W1505831706 abstract "Intercellular cell adhesion molecules-1 (ICAM-1) and vascular cell adhesion molecules-1 (VCAM-1) are expressed in a high quantity on hepatocytes and at the level of endothelium cells from sinusoidal vessels in the liver tissue of patients with chronic hepatitis C. The soluble forms of these molecules sICAM-1 and sVCAM-1 can be determined in the serum of patients through the immunoenzymatic technique (ELISA).of the study was to analyse the base level of these molecules and the changes induced through the combined treatment of interferon-alpha (IFN- alpha) and ribavirin (Rib).Twenty patients suffering from viral chronic hepatitis C were studied: 10 patients responded completely to antiviral treatment and 10 patients showed no response at the end of the treatment. At the end of the therapy patients were placed under biochemical observation for a further six months. The serum concentration of sICAM-1 and sVCAM-1 was measured using ELISA assay at the beginning and the end of the combined treatment: six months IFN 3MU (three times a week) associated with Rib.Statistically, a significant correlation was observed between the values of sICAM-1 pretreatment and the level of viremia, gamma glutamiltrans-peptidase (GGT), but without correlation to the alanin amino transferase (ALT) level. The value of sICAM-1 was significantly higher in patients who had fibrosis score F: 3-4. After the treatment, the serum concentration of sICAM-1 dropped significantly in patients with sustained biochemical response in comparison to patients who had an unsustained response or had no response whatsoever. A significant correlation between the sVCAM-1 pre-treatment value and the level of viremia, GGT, ALT was not established.The level of sICAM-1 could be a useful parameter in the observation of the disease evolution of patients with viral chronic hepatitis C treated with IFN-alpha and Rib." @default.
- W1505831706 created "2016-06-24" @default.
- W1505831706 creator A5031146961 @default.
- W1505831706 creator A5055547891 @default.
- W1505831706 creator A5057806461 @default.
- W1505831706 creator A5073020914 @default.
- W1505831706 creator A5085733361 @default.
- W1505831706 date "2003-06-01" @default.
- W1505831706 modified "2023-09-23" @default.
- W1505831706 title "Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferon-alpha + ribavirin therapy." @default.
- W1505831706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12853993" @default.
- W1505831706 hasPublicationYear "2003" @default.
- W1505831706 type Work @default.
- W1505831706 sameAs 1505831706 @default.
- W1505831706 citedByCount "1" @default.
- W1505831706 crossrefType "journal-article" @default.
- W1505831706 hasAuthorship W1505831706A5031146961 @default.
- W1505831706 hasAuthorship W1505831706A5055547891 @default.
- W1505831706 hasAuthorship W1505831706A5057806461 @default.
- W1505831706 hasAuthorship W1505831706A5073020914 @default.
- W1505831706 hasAuthorship W1505831706A5085733361 @default.
- W1505831706 hasConcept C126322002 @default.
- W1505831706 hasConcept C141071460 @default.
- W1505831706 hasConcept C16224149 @default.
- W1505831706 hasConcept C203014093 @default.
- W1505831706 hasConcept C2522874641 @default.
- W1505831706 hasConcept C2775944032 @default.
- W1505831706 hasConcept C2776178377 @default.
- W1505831706 hasConcept C2776185481 @default.
- W1505831706 hasConcept C2776455275 @default.
- W1505831706 hasConcept C2780040827 @default.
- W1505831706 hasConcept C2909179924 @default.
- W1505831706 hasConcept C2909375385 @default.
- W1505831706 hasConcept C3020491458 @default.
- W1505831706 hasConcept C49453240 @default.
- W1505831706 hasConcept C64943373 @default.
- W1505831706 hasConcept C71924100 @default.
- W1505831706 hasConcept C90924648 @default.
- W1505831706 hasConceptScore W1505831706C126322002 @default.
- W1505831706 hasConceptScore W1505831706C141071460 @default.
- W1505831706 hasConceptScore W1505831706C16224149 @default.
- W1505831706 hasConceptScore W1505831706C203014093 @default.
- W1505831706 hasConceptScore W1505831706C2522874641 @default.
- W1505831706 hasConceptScore W1505831706C2775944032 @default.
- W1505831706 hasConceptScore W1505831706C2776178377 @default.
- W1505831706 hasConceptScore W1505831706C2776185481 @default.
- W1505831706 hasConceptScore W1505831706C2776455275 @default.
- W1505831706 hasConceptScore W1505831706C2780040827 @default.
- W1505831706 hasConceptScore W1505831706C2909179924 @default.
- W1505831706 hasConceptScore W1505831706C2909375385 @default.
- W1505831706 hasConceptScore W1505831706C3020491458 @default.
- W1505831706 hasConceptScore W1505831706C49453240 @default.
- W1505831706 hasConceptScore W1505831706C64943373 @default.
- W1505831706 hasConceptScore W1505831706C71924100 @default.
- W1505831706 hasConceptScore W1505831706C90924648 @default.
- W1505831706 hasIssue "2" @default.
- W1505831706 hasLocation W15058317061 @default.
- W1505831706 hasOpenAccess W1505831706 @default.
- W1505831706 hasPrimaryLocation W15058317061 @default.
- W1505831706 hasRelatedWork W1505831706 @default.
- W1505831706 hasRelatedWork W158907189 @default.
- W1505831706 hasRelatedWork W1996352524 @default.
- W1505831706 hasRelatedWork W1997517818 @default.
- W1505831706 hasRelatedWork W2051044840 @default.
- W1505831706 hasRelatedWork W2143125362 @default.
- W1505831706 hasRelatedWork W2150102564 @default.
- W1505831706 hasRelatedWork W2374920454 @default.
- W1505831706 hasRelatedWork W2419349742 @default.
- W1505831706 hasRelatedWork W2462498398 @default.
- W1505831706 hasVolume "12" @default.
- W1505831706 isParatext "false" @default.
- W1505831706 isRetracted "false" @default.
- W1505831706 magId "1505831706" @default.
- W1505831706 workType "article" @default.